MORGAN STANLEY PLC/PUT/MERCK & CO./125/0.1/19.09.25 Share Price

Warrant

DE000ME80SM1

Market Closed - Bid/Ask 19:29:46 27/06/2024 BST After market 19:52:51
0.91 EUR +21.33% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./125/0.1/19.09.25 0.865 -4.95%
Current month-22.68%
1 month-7.41%
Date Price Change
27/06/24 0.91 +21.33%
26/06/24 0.75 +4.17%
25/06/24 0.72 -2.70%
24/06/24 0.74 -8.64%
21/06/24 0.81 +2.53%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 07:29 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME80SM
ISINDE000ME80SM1
Date issued 31/01/2024
Strike 125 $
Maturity 19/09/2025 (449 Days)
Parity 10 : 1
Emission price 1.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.23
Lowest since issue 0.71
Delta-0.37x
Omega 4.988
Premium10.02x
Gearing13.55x
Moneyness 0.9736
Difference Strike -3.81 $
Difference Strike %-3.05%
Spread 0.01
Spread %1.12%
Theoretical value 0.8850
Implied Volatility 23.08 %
Total Loss Probability 54.33 %
Intrinsic value 0.000000
Present value 0.8850
Break even 115.53 €
Theta-0.01x
Vega0.05x
Rho-0.05x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus